Phase 0 trial investigating the intra-tumoural concentration and activity of Sorafenib in Neurofibromatosis type 2
| dc.contributor.author | Hanemann, Clemens Oliver | |
| dc.contributor.author | Ammoun, Sylwia | |
| dc.contributor.author | Evans, G | |
| dc.contributor.author | Hilton, DA | |
| dc.contributor.author | Streeter, Adam | |
| dc.contributor.author | Hayward, C | |
| dc.date.accessioned | 2019-01-16T10:14:37Z | |
| dc.date.issued | 2019-02-04 | |
| dc.identifier.issn | 0022-3050 | |
| dc.identifier.issn | 1468-330X | |
| dc.identifier.uri | http://hdl.handle.net/10026.1/13150 | |
| dc.format.extent | 1184-1187 | |
| dc.format.medium | Print-Electronic | |
| dc.language | en | |
| dc.language.iso | en | |
| dc.publisher | BMJ Publishing Group | |
| dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International | |
| dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International | |
| dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International | |
| dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International | |
| dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International | |
| dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International | |
| dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International | |
| dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International | |
| dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International | |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | |
| dc.subject | neurofibromatosis | |
| dc.subject | neurooncology | |
| dc.subject | Adult | |
| dc.subject | Antineoplastic Agents | |
| dc.subject | Blotting, Western | |
| dc.subject | Caspase 3 | |
| dc.subject | Cyclin D1 | |
| dc.subject | Humans | |
| dc.subject | Immunohistochemistry | |
| dc.subject | Leukocytes, Mononuclear | |
| dc.subject | Mitogen-Activated Protein Kinase 1 | |
| dc.subject | Mitogen-Activated Protein Kinase 3 | |
| dc.subject | Molecular Targeted Therapy | |
| dc.subject | Neurofibromatosis 2 | |
| dc.subject | Proto-Oncogene Proteins c-akt | |
| dc.subject | Receptor, Platelet-Derived Growth Factor beta | |
| dc.subject | Ribosomal Protein S6 | |
| dc.subject | Sorafenib | |
| dc.title | Phase 0 trial investigating the intra-tumoural concentration and activity of Sorafenib in Neurofibromatosis type 2 | |
| dc.type | journal-article | |
| dc.type | Letter | |
| dc.type | Research Support, Non-U.S. Gov't | |
| plymouth.author-url | https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000487463400018&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=11bb513d99f797142bcfeffcc58ea008 | |
| plymouth.issue | 10 | |
| plymouth.volume | 90 | |
| plymouth.publication-status | Published | |
| plymouth.journal | Journal of Neurology, Neurosurgery and Psychiatry | |
| dc.identifier.doi | 10.1136/jnnp-2018-319713 | |
| plymouth.organisational-group | /Plymouth | |
| plymouth.organisational-group | /Plymouth/Faculty of Health | |
| plymouth.organisational-group | /Plymouth/Faculty of Health/Peninsula Medical School | |
| plymouth.organisational-group | /Plymouth/REF 2021 Researchers by UoA | |
| plymouth.organisational-group | /Plymouth/REF 2021 Researchers by UoA/UoA01 Clinical Medicine | |
| plymouth.organisational-group | /Plymouth/REF 2021 Researchers by UoA/UoA03 Allied Health Professions, Dentistry, Nursing and Pharmacy | |
| plymouth.organisational-group | /Plymouth/Research Groups | |
| plymouth.organisational-group | /Plymouth/Research Groups/Institute of Health and Community | |
| plymouth.organisational-group | /Plymouth/Research Groups/Institute of Translational and Stratified Medicine (ITSMED) | |
| plymouth.organisational-group | /Plymouth/Research Groups/Institute of Translational and Stratified Medicine (ITSMED)/CBR | |
| plymouth.organisational-group | /Plymouth/Research Groups/Institute of Translational and Stratified Medicine (ITSMED)/CCT&PS | |
| plymouth.organisational-group | /Plymouth/Research Groups/Plymouth Institute of Health and Care Research (PIHR) | |
| plymouth.organisational-group | /Plymouth/Users by role | |
| plymouth.organisational-group | /Plymouth/Users by role/Academics | |
| plymouth.organisational-group | /Plymouth/Users by role/Researchers in ResearchFish submission | |
| dc.publisher.place | England | |
| dcterms.dateAccepted | 2019-01-16 | |
| dc.rights.embargodate | 2019-12-7 | |
| dc.identifier.eissn | 1468-330X | |
| dc.rights.embargoperiod | Not known | |
| rioxxterms.versionofrecord | 10.1136/jnnp-2018-319713 | |
| rioxxterms.licenseref.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | |
| rioxxterms.licenseref.startdate | 2019-02-04 | |
| rioxxterms.type | Journal Article/Review |
Files in this item
This item appears in the following Collection(s)
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivatives 4.0 International